RBD-1073

N/A

Report date: 2025/04/11 14:45:50
NME

Base Information

Drug NameRBD-1073
Drug Alias NameRBD-1073RBD1073RBD-9090RBD9090
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of Action17-beta-hydroxysteroid dehydrogenase 13 inhibitorsAsialoglycoprotein receptor modulatorsRNA interference
Targets17-beta-hydroxysteroid dehydrogenase 13Asialoglycoprotein receptor
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Ribo Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A